ASD vs. IDNA
ASD (Defiance Autism Impact ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds. A 0.71 correlation means they provide meaningful diversification when combined. ASD charges 0.79%/yr vs 0.47%/yr for IDNA.
Performance
ASD vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
ASD
- 1D
- 0.34%
- 1M
- 9.28%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- -1.42%
- 1M
- 9.31%
- 6M
- 16.31%
- YTD
- 25.19%
- 1Y
- 54.34%
- 3Y*
- 12.07%
- 5Y*
- -6.60%
- 10Y*
- —
ASD vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
ASD Defiance Autism Impact ETF | 10.03% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 11.83% |
Correlation
The correlation between ASD and IDNA is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 2, 2026 | 0.71 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASD vs. IDNA — Risk / Return Rank
ASD
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IDNA
ASD vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Defiance Autism Impact ETF (ASD) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASD | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.34 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 5.12 | — |
| Martin ratioReturn relative to average drawdown | — | 14.05 | — |
Loading charts...
Drawdowns
ASD vs. IDNA - Drawdown Comparison
The maximum ASD drawdown since its inception was -2.93%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for ASD and IDNA.
Loading charts...
Drawdown Indicators
| ASD | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -2.93% | -68.26% | +65.33% |
Max Drawdown (1Y)Largest decline over 1 year | — | -10.66% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -29.46% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -2.09% | -38.27% | +36.18% |
Average DrawdownAverage peak-to-trough decline | -0.92% | -36.28% | +35.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.88% | — |
Volatility
ASD vs. IDNA - Volatility Comparison
Loading charts...
Volatility by Period
| ASD | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.13% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 18.71% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 16.70% | 25.18% | -8.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.70% | 28.52% | -11.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.70% | 29.49% | -12.79% |
ASD vs. IDNA - Expense Ratio Comparison
ASD has a 0.79% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
ASD vs. IDNA - Dividend Comparison
ASD's dividend yield for the trailing twelve months is around 0.02%, less than IDNA's 0.86% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ASD Defiance Autism Impact ETF | 0.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.86% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
ASD and IDNA have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IDNA is cheaper at 0.47% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.79% for ASD.
IDNA has the higher dividend yield at 0.86%, compared with 0.02% for ASD.
They also come from different issuers: Defiance and iShares. Their fees differ too: 0.79% for ASD and 0.47% for IDNA.
Find the right allocation for ASD and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer